NCT00417859

Brief Summary

The goal of this study is to provide gait parameters as a new objective method to assess total knee arthroplasty outcome between patients with fixed- and mobile-bearing, using an ambulatory device with minimal sensor configuration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Feb 2004

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2004

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

January 3, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 4, 2007

Completed
8.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
4.4 years until next milestone

Results Posted

Study results publicly available

April 7, 2020

Completed
Last Updated

April 21, 2020

Status Verified

April 1, 2020

Enrollment Period

11.8 years

First QC Date

January 3, 2007

Results QC Date

February 27, 2020

Last Update Submit

April 7, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Gait Stride Length

    distance in meters of gait stride lenght measured by a data logger with five inertial sensors

    5years

  • EuroQoL Quality of Life Scale (EQ-5D)

    The EQ-5D is a measure of self-reported health outcomes that is applicable to a wide range of health conditions and treatments. It consists of two parts: a descriptive system (Part I) and a visual analogue scale (VAS) (Part II). Part I of the scale consists of 5 single-item dimensions including: mobility, self care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has a 3 point response scale designed to indicate the level of the problem. Part II uses a vertical graduated VAS (thermometer) to measure health status, ranging from worst imaginable health state to best imaginable health state. T. Descriptive data from the 5 dimensions of Part I can be used to generate a health-related quality of life profile for the subject. Part II is scored from 0 (worst health state imaginable) to 100 (best health state imaginable). The score from Part II can be used to track changes in health, on an individual or group level, over time.

    5years

Secondary Outcomes (2)

  • Semi-objective Evaluation Knee Sciety Score (KSS) Clinical Outcome Measures

    5years

  • Number of Participants With Dislocation

    5years

Study Arms (2)

TKA mobile

ACTIVE COMPARATOR

TKA mobile

Device: Total knee arthroplasty: mobile bearing

TKA

NO INTERVENTION

TKA fix

Interventions

Total knee arthroplasty: mobile bearing

TKA mobile

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients suffering from a primary unilateral knee osteoarthritis and requiring a knee replacement
  • Informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HOSR

Lausanne, Switzerland

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Results Point of Contact

Title
Prof Brigitte Jolles
Organization
University Hospital of Lausanne

Study Officials

  • B Jolles, MD MSc

    HOSR

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

January 3, 2007

First Posted

January 4, 2007

Study Start

February 1, 2004

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

April 21, 2020

Results First Posted

April 7, 2020

Record last verified: 2020-04

Locations